参考文献/References:
[1] Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis[J]. Lancet,2016,387(10022): 957-967.
[2] O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring[J]. J Hypertens,2013,31(9): 1731-1768.
[3] Schwartz JE, Burg MM, Shimbo D, et al. Clinic blood pressure underestimates ambulatory blood pressure in an untreated employer-based US population: results from the masked hypertension study[J]. Circulation,2016,134(23): 1794-1807.
[4] Gabb GM, Mangoni AA, Anderson CS, et al. Guideline for the diagnosis and management of hypertension in adults - 2016[J]. Med J Aust,2016,205(2): 85-89.
[5] Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children[J]. Can J Cardiol,2018,34(5):506-525.
[6] Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)[J]. Circulation,2001,104(12): 1385-1392.
[7] Omboni S, Aristizabal D, de la Sierra A, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study[J]. J Hypertens,2016,34(11): 2187-2198.
[8] Franklin SS, Thijs L, Hansen TW, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population[J]. Hypertension,2012,59(3):564-571.
[9] Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension[J]. Hypertension,2009,54(2): 226-232.
[10] Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality[J]. N Engl J Med,2018, 378(16):1509-1520.
[11] Cuspidi C, Sala C, Grassi G, et al. White coat hypertension: to treat or not to treat? [J]. Curr Hypertens Rep,2016,18(11): 80.
[12] Melgarejo JD, Maestre GE, Thijs L, et al. Prevalence, treatment, and control rates of conventional and ambulatory hypertension across 10 populations in 3 continents[J]. Hypertension,2017,70(1):50-58.
[13] Palla M, Saber H, Konda S, et al. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis[J]. Integr Blood Press Control, 2018,11:11-24.
[14] Trudel X, Milot A, Brisson C. Persistence and progression of masked hypertension: a 5-year prospective study[J]. Int J Hypertens,2013,2013: 836387.
[15] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension[J]. J Hypertens,2018,36(10): 1953-2041.
[16] Franklin SS, O’Brien E, Staessen JA. Masked hypertension: understanding its complexity[J]. Eur Heart J,2017,38(15): 1112-1118.
[17] Li Y, Thijs L, Hansen TW,et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations[J]. Hypertension,2010,55(4): 1040-1048.
[18] Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications[J]. Hypertension,2012, 60(1): 34-42.
[19] Sheppard JP, Hodgkinson J, Riley R, et al. Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review[J]. Am J Hypertens,2015, 28(1): 30-41.
[20] Salles GF, Reboldi G, Fagard RH, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis[J]. Hypertension,2016,67(4): 693-700.
[21] Mezue K, Isiguzo G, Madu C, et al. Nocturnal non-dipping blood pressure profile in black normotensives is associated with cardiac target organ damage[J]. Ethn Dis,2016,26(3):279-284.
[22] Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study[J]. Circulation,2005,111(14): 1777-1783.
[23] Hsu PF, Cheng HM, Wu CH, et al. High short-term blood pressure variability predicts long-term cardiovascular mortality in untreated hypertensives but not in normotensives [J]. Am J Hypertens,2016,29(7):806-813.
[24] Dolan E, O’Brien E. Is it daily, monthly, or yearly blood pressure variability that enhances cardiovascular risk? [J]. Curr Cardiol Rep,2015,17(11): 93.
[25] Hansen TW, Thijs L, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations[J]. Hypertension,2010,55(4): 1049-1057.
[26] Leoncini G, Ratto E, Viazzi F, et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension[J]. Hypertension,2006,48(3):397-403.
[27] Muxfeldt ES, Cardoso CR, Dias VB, et al. Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension[J].J Hypertens,2010,28(7): 1547-1553.
[28] Schrader J, Luders S, Zuchner C, et al. Practice vs ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): a randomised, prospective long-term study to evaluate the benefits of ABPM in patients on antihypertensive treatment[J]. J Hum Hypertens,2000,14(7):435-440.
[29] Soranna D, Zambon A, Corrao G, et al. Different effects of antihypertensive treatment on office and ambulatory blood pressure: a meta-analysis[J]. J Hypertens,2019,37(3):467-475.
[30] Mancia G, Parati G, Bilo G, et al. Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)[J]. Hypertension,2012,60(6): 1400-1406.
[31] Lu DY, You LK, Sung SH, et al. Abnormal pulsatile hemodynamics in hypertensive patients with normalized 24-hour ambulatory blood pressure by combination therapy of three or more antihypertensive agents[J]. J Clin Hypertens,2016,18(4): 281-289.
[32] 王文张维忠孙宁玲等.中国血压测量指南[J].中华高血压杂志,2011,19(12): 1101-1115.
[33] de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8 295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring[J]. Hypertension,2011,57(5): 898-902.
[34] Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension[J]. Eur Heart J,2014,35(46): 3304-3312.
[35] Stergiou GS, Asayama K, Thijs L, et al. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome[J]. Hypertension,2014,63(4): 675-682.
[36] Hermida RC, Ayala DE, Mojon A, et al. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study[J]. Chronobiol Int,2010,27(8): 1629-1651.
[37] Castilla-Guerra L, Fernandez-Moreno Mdel C. Chronic management of hypertension after stroke: the role of ambulatory blood pressure monitoring[J]. J Stroke,2016,18(1): 31-37.
[38] Krmar RT, Ferraris JR. Clinical value of ambulatory blood pressure in pediatric patients after renal transplantation[J]. Pediatr Nephrol,2018,33(8): 1327-1336.
[39] Bello NA, Miller E, Cleary K, et al. Out of office blood pressure measurement in pregnancy and the postpartum period[J]. Curr Hypertens Rep,2018,20(12): 101.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(6):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(6):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(6):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(6):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[6]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(6):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[7]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[8]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(6):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[9]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(6):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[10]付士辉李玉龙骆雷鸣沈明志田进文邓珏琳.高血压基础研究现状与进展[J].心血管病学进展,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
FU ShihuiLI YulongLUO LeimingSHEN MingzhiTIAN JinwenDENG Juelin.Status and Progress of Basic Researches about Hypertension[J].Advances in Cardiovascular Diseases,2019,(6):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]